Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neu-001 in adult amblyopia
CTR20260276Phase 2Active
- Sponsor
- NeuDirection
- Start
- Feb 2026
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of NEU-001 in amblyopia, sponsored by NeuDirection. Started Feb 2026; status: active.
02
Drugs
NEU-001
03
Conditions
amblyopia
Beyond the preview
Go deeper on CTR20260276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260276.